July 2018: NICE has made new recommendations on treat-to-target strategy, initial
pharmacological management, symptom control and monitoring. The recommendations and …

Background We systematically reviewed current guidelines for managing rheumatoid
arthritis (RA) to evaluate their range and nature, assess variations in their recommendations …

Rheumatoid arthritis (RA) is the most common systemic inflammatory rheumatic disease. It is
associated with significant burden at the patient and societal level. Extensive efforts have …

Autoimmunity was rediscovered in the 1950s. Rediscovered is the appropriate term because
evidence for autoimmunity emerged around the turn of the last century. For reasons that I …

Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease influenced by both
genetic and environmental factors. It has been postulated that a high-risk genetic …

Background & Aims Rheumatoid arthritis (RA) is a prototypic autoimmune disease causing
inflammatory polyarthritis that affects nearly 1% of the population. RA can lead to joint …

Elderly-onset rheumatoid arthritis (EORA) is prevalent among older patients, and its
incidence is increasing due to aging societies. However, differentiating between EORA and …

CLIN EXP RHEUM 31/2/2013 161-326 Page 1 Clinical and Experimental Rheumatology 2013;
31: 350-357. Understanding the patient perspective – results of the Rheumatoid Arthritis …

The information used by rheumatologists when delivering care to patients with rheumatoid
arthritis (RA) is derived mainly from two sources: randomised controlled clinical trials and …

For more than 30 years, the highly regarded Secrets Series® has provided students and
practitioners in all areas of health care with concise, focused, and engaging resources for …